AANEM Practice News Express

AANEM News Express

Medicare PQRS and QRUR Reports Available Now!

The 2015 Physician Quality Reporting System (PQRS) Feedback Reports and the 2015 Annual Quality and Resource Use Reports (QRURs) were released on September 26, 2016.  

AANEM Releases Position Statement on Proper Performance of Autonomic Testing

AANEM has developed a
position statement regarding the proper performance of autonomic testing. This position statement was created to assist payers in the development of their medical coverage policies for these tests.

2017 Proposed Physician Fee Schedule—What Could This Rule Mean for Reimbursement?

On July 7, 2016, the Center for Medicare and Medicaid Services (CMS) issued a
proposed rule updating payment policies and payment rates for physicians under the Medicare Physician Fee Schedule (MPFS) for 2017. Within this document and addendum are updates to the relative value units (RVU), which include work RVUs, practice expense (PE) RVUs, malpractice (MP) RVUs, as well as the proposed Medicare conversion factor.

CMS Releases Proposed 2017 Medicare Physician Fee Schedule

On July 7, 2016, the Centers for Medicare & Medicaid Services (CMS) issued a
proposed rule updating payment policies and payment rates for physicians under the Medicare Physician Fee Schedule (MPFS) for 2017. CMS estimates a +1% impact in payment on neurology and physical medicine and rehabilitation physicians; although, ultimately, the result could differ when the final rule is published in the fall.

AANEM Releases Position Statement on Genetic Testing in Diagnosis of NM Disease

AANEM has developed a
position statement regarding the utility of genetic testing in neuromuscular (NM) disease. This position statement was prompted by inquiries from members and insurance providers regarding whether genetic testing for NM diseases is valuable and beneficial in light of the costs of testing.

Summary of Merit-based Incentive Payment System (MIPS)

Under MACRA, a new framework of payment called the “Quality Payment Program (QPP)” has been proposed. Under the QPP, physicians will be required to utilize one of two paths for reimbursement: Merit-based Incentive Payment System (MIPS) and Advanced Alternative Payment Models (APMs). It is expected that the majority of physicians will be subject to the MIPS path, at least in the first few years.

Positive Effects of Bisphosphonates on Bone and Muscle in a Mouse Model of Duchenne Muscular Dystrophy

This study in Neuromuscular Disorders supports a possible beneficial effect of pamidronate on bone and muscle health in the Mdx mouse.

Recognition and Management of Acute Flaccid Myelitis in Children

This retrospective study in PediatricNeurology points out the importance of early imaging in pediatric patients who present with acute flaccid myelitis, and confirms the poor prognosis of return to complete function of an affected limb with acute flaccid myelitis. 

The NorthStar Ambulatory Assessment in Duchenne Muscular Dystrophy: Considerations for the Design of Clinical Trials

This study in the Journal of Neurology, Neurosurgery & Psychiatry and Annals of Neurology helps quantify the motor gains expected of boys with DMD undergoing both early and late glucocorticoid therapy and can serve as a gauge for the standard of care and declines experienced by ambulatory boys with DMD using the NSAA tool. 

Zika Virus: What You Need to Know

Faculty experts at LSU Health New Orleans schools of Medicine and Public Health, along with Dr. Rebekah Gee, Secretary of the Louisiana Department of Health and Hospitals, plan to share the latest information about the Zika Virus and what people need to know at an event on Monday, May 23, 2016, at 5:30 p.m. As a service to the Health Sciences Center and medical communities outside of New Orleans, the event will be streamed live online and then posted afterwards.







Devon products